2 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Nut Hypersensitivity: new trials by email Literature Review of Nut Hypersensitivity trials Research Report on Nut Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Study of Cizutamig in IgE Mediated Diseases Cizutamig - IgE-Mediated Hypersensitivity, IgE Mediated Food Allergy | Phase 1 | Withdrawn | Candid Therapeutics | 2026-04-01 | 2026-07-22 | |
| Walnut Oral Immunotherapy for Tree Nut Allergy Walnut Protein Flour, Oat flour - Nut Hypersensitivities | Phase 1 / Phase 2 | Withdrawn | University of North Carolina, Chapel Hill | 2013-11-01 | 2016-06-17 |
Asthma (1) · Dermatitis, Atopic (1) · Egg Hypersensitivity (1) · Food Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Milk Hypersensitivity (1) · Peanut Hypersensitivity (1) · Rhinitis, Allergic (1) · Rhinosinusitis (1) · Urticaria (1) · Wheat Hypersensitivity (1)
Hypersensitivity (2) · Immune System Diseases (2) · Nut and Peanut Hypersensitivity (2) · Bronchial Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dermatitis (1) · Food Hypersensitivity (1) · Genetic Diseases, Inborn (1) · Hypersensitivity, Immediate (1) · Infections (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Nose Diseases (1) · Otorhinolaryngologic Diseases (1) · Paranasal Sinus Diseases (1)
Candid Therapeutics (1) · University of North Carolina, Chapel Hill (1)
Australia (1)
Edwin Kim, MD (1) · Wesley Burks, MD (1)